SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy-Reference-Cited by-同舟云学术

SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy

Published:2018-01 Issue:1 Volume:126 Page:125-131
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

De-Colle Chiara,Menegakis Apostolos,Mönnich David,Welz Stefan,Boeke Simon,Sipos Bence,Fend Falko,Mauz Paul-Stefan,Tinhofer Inge,Budach Volker,Abu Jawad Jehad,Stuschke Martin,Balermpas Panagiotis,Rödel Claus,Grosu Anca-Ligia,Abdollahi Amir,Debus Jürgen,Belka Claus,Ganswindt Ute,Pigorsch Steffi,Combs Stephanie E.,Lohaus Fabian,Linge Annett,Krause Mechthild,Baumann Michael,Zips Daniel

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference52 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

3. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy;Huguenin;J Clin Oncol,2004

4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

5. Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry;Diagnostics;2024-06-28

2. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment;Experimental Hematology & Oncology;2023-12-08

3. Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles;Environmental Research;2023-12

4. A Systematic Review on a comprehensive evaluation of clinical prognostic variables and new biomarkers for head and neck cancer outcome;2022-11-30

5. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model;Pharmaceutics;2022-04-18